Panelists discuss how healthcare resource utilization is primarily driven by hospitalizations, medication costs, and ...

In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

Bronchiectasis causes your airways, called bronchi, to become damaged and widened over time. When you have bronchiectasis, ...

Antibiotic demand for pneumonia and COPD in the top 20 countries showed high global consumption. Researchers conducted a ...

With the demand for affordable health care rising across Ohio, health officials are cautioning that funding for free and ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment ...

A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...